Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

ASCO Partners With FDA to Incorporate Real-World Evidence Into Drug Decisions

June 9th 2017

In recognition of the potential for real-world evidence to significantly improve the way patients with cancer are treated, CancerLinQ has formed new partnerships with the US government that are expected to coordinate the sharing of patient data and incorporate that information into the FDA regulatory process.

Tennessee Oncology Group Finds Growth Bonanza in Clinical Trials

June 9th 2017

After a trio of mergers and sustained organic growth, Tennessee Oncology has 81 physicians who provide care in 30 locations in central and east Tennessee.

Experts Say Current Patient Portals Leave Much Room for Improvement

June 9th 2017

For about a decade, patient portals have been hailed as the wave of the future. However, many still require some work before they reach peak functionality, partly because many patients are reluctant to use them.

Pharmacies Are Wary of Risking Revenues to Promote Value-Based Care

June 8th 2017

Major pharmacy companies are paying attention to the movement toward value-based care in oncology, but recent comments from representatives of 2 top firms suggest this sector is wary of risking capital to lower costs and improve patient outcomes.

ACOs Rapidly Expand, But Cost and Quality Improvements Lag Behind

June 8th 2017

The number of accountable care organizations across the country has grown rapidly in the last 5 years, creating opportunities and challenges for oncology practices as they seek to benefit from the organizations’ referral networks, shared-savings programs, and care-improvement efforts.

High-Tech Solutions for Prior Authorization Problems

June 7th 2017

Several provider challenges and opportunities were highlighted during the 2017 State Oncology Society Forum, hosted by the National Comprehensive Cancer Network at its annual conference, held in March in Orlando.

Pilot Study Will Test the Combined Power of Watson for Oncology and Cota

June 2nd 2017

Hackensack Meridian Health will pilot a study using IBM's Watson for Oncology and Cota.

QuintilesIMS Report: US Cancer Costs Are up $20 Billion Since 2011

June 1st 2017

Driven by newer agents, the cost of US oncology medicines has increased 88% over the past 5 years, according to the QuintilesIMS Institute Global Oncology Trends 2017 report.

ASCO 2017: Same-Day Dosing Cuts Costs

May 26th 2017

Researchers achieved cost savings and cut down on the amount of drug they had to throw away by pooling drug vials and dosing all patients with a given disease on the same day of the week, according to data released ahead of the 2017 ASCO Annual Meeting.

FDA Grants Nivolumab Priority Review for Liver Cancer

May 26th 2017

The FDA has granted a priority review designation to nivolumab (Opdivo) for use as a treatment for patients with hepatocellular carcinoma following prior sorafenib (Nexavar).

Weaving Through the Landscape of HER2-Positive Breast Cancer

May 23rd 2017

Adam M. Brufsky, MD, PhD, discusses neratinib, overcoming resistance to HER2-targeted therapy, and the impact of newer agents in HER2-positive breast cancer.

ASCO 2017: Improving the Patient-Doctor Immunotherapy Discussion

May 22nd 2017

Ahead of this year's meeting, researchers are increasingly interested in the state of communication between patients and doctors on immunotherapy.

A Boot Camp Opens for Oncology Financial Navigators

May 18th 2017

Clara N. Lambert and the Association of Community Cancer Centers have created an online course called Financial Advocacy Boot Camp, which is designed to give experienced and novice financial navigators a review of essential knowledge for finding patient funds.

Affordable Care Act Positively Affects Stage at Diagnosis

May 18th 2017

More Stage I cancers were diagnosed after the passage of the Affordable Care Act within five screenable disease types than were diagnosed before ACA implementation.

FDA Grants Priority Review to Copanlisib for Follicular Lymphoma

May 17th 2017

The FDA has granted a priority review designation to copanlisib as a treatment for patients with relapsed/refractory follicular lymphoma who have received at 2 least prior therapies, according to Bayer, the manufacturer of the PI3K dual-isoform inhibitor.

Reduce Costs By Using Less Radiotherapy

May 11th 2017

Radiation therapy remains fertile for continued technological innovation that can improve patient outcomes, but of the newest technologies may be practical for only the largest institutions.

Atezolizumab Falls Short in Phase III Bladder Cancer Trial

May 10th 2017

Atezolizumab missed the phase III IMvigor211 trial’s primary endpoint of improving overall survival in the second-line setting for patients with locally advanced or metastatic urothelial carcinoma.

Practices Rush to Prepare for USP

May 9th 2017

Terra Universal, an environmental solutions company based in Fullerton, California, came to a point recently where it was no longer willing to sell and design clean-room setups for oncology practices unless potential clients first sat down with a consultant who could give them reliable guidance on what they needed.

Researchers Perform First Robotic Colonoscopy

May 9th 2017

Researchers have successfully performed autonomous retroflexion of a robotic capsule during colonoscopy in a subject animal, according to data presented during Digestive Disease Week 2017 at McCormick Place in Chicago.

Science Marches On and Policy Lags Behind

May 7th 2017

The research presented at AACR focused on the fundamentals of cell biology, cell aging, and cell death; how the immune system recognizes and kills cancer cells; and how, in turn, cancer cells avoid immune system detection.